These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does intravenous administration of gadoxetate disodium have any effect on breath-hold times. Bergmann K; Agris J; Balzer T Radiology; 2013 Sep; 268(3):926-7. PubMed ID: 23970514 [No Abstract] [Full Text] [Related]
3. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781 [TBL] [Abstract][Full Text] [Related]
4. Can gadopentetate dimeglumine be safely administered more rapidly than the FDA-approved injection rate for liver imaging? Shiehmorteza M; Hanna RF; Middleton MS AJR Am J Roentgenol; 2007 Oct; 189(4):W231. PubMed ID: 17885038 [No Abstract] [Full Text] [Related]
5. Gadoxetic acid-induced acute transient dyspnea: the perspective of Japanese radiologists. Motosugi U Magn Reson Med Sci; 2015; 14(2):163-4. PubMed ID: 25740243 [No Abstract] [Full Text] [Related]
6. A word of caution on the use of high-dose MR contrast media in patients with renal failure. Geckeis K; Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R J Endovasc Ther; 2005 Apr; 12(2):262. PubMed ID: 15823076 [No Abstract] [Full Text] [Related]
16. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality. Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367 [TBL] [Abstract][Full Text] [Related]
17. The need for radiologists' awareness of nephrogenic systemic fibrosis. Aydingöz U Diagn Interv Radiol; 2006 Dec; 12(4):161-2. PubMed ID: 17160795 [No Abstract] [Full Text] [Related]
18. Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan). Decupere M; Ooms V; Oyen R; Kuypers DR; Claes K Nephrol Dial Transplant; 2005 Jul; 20(7):1516-7. PubMed ID: 15886213 [No Abstract] [Full Text] [Related]
19. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger? Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754 [TBL] [Abstract][Full Text] [Related]
20. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent". Runge VM AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887 [No Abstract] [Full Text] [Related] [Next] [New Search]